In Korean, 인정 can carry more than one meaning depending on context. In cultural conversation, it is often used to describe sympathy, kindness, tenderness, or a warm heart that considers and helps others.

In two weeks, CRScube's training and enablement gets PV teams up and running on cubeSAFETY.

This buyer’s guide explains how to evaluate modern clinical trial platforms – especially Electronic Data Capture (EDC) and operational systems like CTMS, RTSM, and eTMF – so organizations can select technology that delivers maximum operational value while remaining cost-effective.

Whether in smartphones, cars, beauty, or entertainment, the Korean companies that succeeded internationally share a common approach.

To drive operational transformation, Linical implemented cubeTMF, a secure, GCP-compliant document management platform designed to centralize control while enabling global scalability.

In South Korea, Lunar New Year is more than a public holiday. It is a pause that makes space for family, reflection, and renewal. Homes prepare, travel routes fill, and routines slow down for a few days.

Safety reporting is moving beyond simple adverse event collection. The future lies in intelligent risk detection and frictionless data capture.

A mid-size biotech needed a safer and more efficient way to move adverse event data from their Electronic Data Capture (EDC) system into their safety database.

For sponsors and CROs, it is crucial to understand the implications of the full enforcement of ICH E2B(R3) standards, especially as it impacts both pre- and post-authorization submissions.

While E2B(R3) standard has existed for some time, global adoption has been gradual. What makes 2026 critical is that many regulatory authorities worldwide have now finalized mandatory transitions.

Innovation in Korea is more than progress - it’s identity. From technology to clinical research, it fuels a mindset of questioning, improving, and reimagining. At CRScube, that same spirit anchors how we design with intent, adapt with agility, and deliver solutions that resonate globally.

EPS adopted cubeCDMS Planned SDV as the foundation of its risk-based monitoring approach, enabling both the strategic and operational execution of risk-based monitoring.

When speaking with David and Marci, we realize how naturally their perspectives complement each other, from their user focus to how they influence product design.

What sets CRScube and Mednet apart is their ability to support global studies with local understanding, regional expertise, and a broad, complementary technology portfolio.

By implementing cubeCTMS, the CRO aligned planning, reporting, and filing for monitoring in one reliable flow. Teams gained live visibility, reduced handoffs, and kept documentation current across countries and sites.

In clinical research, where data integrity, compliance, speed, and usability all matter, having an EDC system that genuinely works makes a huge difference.

Have you heard of KPop Demon Hunters?! The answer is likely to be a resounding “Yes”, even if you haven’t watched the film. It has been a massive success on screen and you’re likely to have heard its catchy theme tunes.

Although both CRScube and Mednet were built in different environments, there is a strong sense of culture and belonging at their core.

From halting patient recruitment and struggling with the shipment of investigational medicines, to relocating vulnerable oncology patients across borders, Anna paints a vivid picture of resilience and resourcefulness under pressure.

CRScube and Mednet are a natural fit. We are both innovators in eClinical technology. We both operate on a SaaS model, serve the same customers, and believe in transforming clinical trials.

“Bringing CRScube and Mednet together is an important milestone in our journey to transform clinical trials" said Stanley Kim, CEO of CRScube.

Sylvain and Scott explore the growing uncertainty created by political change, regulatory shifts, and economic pressures, and how these factors are shaping sponsor strategies.

Sharing a meal might seem like a simple act. But in Korean workplace culture, it carries a deeper purpose, one that goes beyond food. It’s called Hweshik (회식), a time to step away from the workday and engage in connection, laughter, and camaraderie.

By implementing cubeCDMS, the sponsor successfully enabled Independent Radiological Review using raw DICOM files, ensuring unbiased and reliable endpoint evaluations.

In CRScube’s 2025 Study Team Net Promoter Score (NPS) survey, clinical professionals shared their experience using cubeCDMS, our EDC system. The results highlight what users value most in modern clinical data capture platforms.

Dr. Marek Wasiluk brings a unique perspective on how clinical research organizations can embrace innovation while safeguarding trial quality.

A pioneer in implementing eSource during his years at AstraZeneca, Mats shares how this approach is transforming clinical research.

Embracing Hangul means recognizing the power of purposeful design to create access and connection. At CRScube, it inspires how we simplify complexity, widening access to tools and insights so every team can succeed.

For many years, CMIC relied on conventional methods – EDC, CTMS, and Excel trackers – to perform risk assessments.

Sylvain and Joe discuss how real-time data capture accelerates decision-making and improves quality, and why designing systems around the patient experience is critical to compliance and study success.

Harnessing data surveillance means transforming trial oversight from reactive to proactive. It enables early signal detection, cross-functional alignment, and stronger safeguards for both data integrity and patient safety.

In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Tanya Du Plessis, Chief Data Strategist and Solutions Officer at Bioforum, to unpack what data surveillance really means.

Embracing Nunchi means nurturing intuitive awareness to build deeper connections. At CRScube, it's foundational: guiding how we listen, understand, and anticipate client needs.

We are thrilled to share that cubeCDMS has achieved the #1 position for User Satisfaction on G2.com, an independent software marketplace and peer-to-peer review platform. This recognition is especially meaningful because it comes directly from the voices of our users.

To better understand what users prefer in an EDC system, we surveyed 477 CRCs and CRAs who actively use cubeCDMS, our clinical data management system.

VSPharmTech has selected digital clinical trial solution provider CRScube as partners for its U.S. FDA Phase 2 clinical trial of its radiation sensitizer candidate, VS-101.

The recognition from G2 reflects what matters most to us: the experience of the teams on the ground.

We are pleased to host CRScube Geekfest 2025, our user conference in Japan, on Monday, June 16th, 2025, for pharmaceutical companies, CROs, and academia representatives who are currently using or considering implementing CRScube’s solutions.

Cristina shares her deep insights into how real-world data is being applied to clinical trials to enhance patient outcomes, regulatory submissions, and post-marketing strategies.

The reliance on paper-based source documents and subsequent transcription into an Electronic Data Capture (EDC) system led to transcription errors, delayed data entry, and increased source data verification (SDV) costs.

This European CRO’s decision to implement a combined approach with cubeCDMS and cubeIWRS provided them with an integrated, cost-effective, and innovative solution.

This client leveraged cubeCDMS to reduce direct costs by an estimated 50-60% compared to their original EDC vendor.

A biotech company simplified their safety reporting, streamlined compliance and eliminated hidden fees.

A leading CRO swiftly investigated a 66% screening failure rate, saving a clinical trial's timeline with proactive risk management.

This biotech company enhanced data quality and patient safety, with CRScube's risk-based monitoring solution.

The sponsor adopted cubeCDMS for their phase 2 and phase 3 portfolio, boosting their data management efficiency.

This top 10 Korean pharma reduced its monitoring costs through risk-based monitoring, while maintaining data quality and regulatory compliance.

This leading pharmaceutical company transformed its pharmacovigilance operations by integrating cubeSAFETY with cubeCDMS.